Postdoc Pay

Concerning the news article "Postdocs get a pay raise, but other issues remain,"1 it is important to note that the pay raise being received by NIH-funded postdocs applies only to those paid from NIH grants awarded after October 1998. Any postdoc who is being paid from an NIH grant dated prior to October 1998 does not receive the increase. While this may be attributed to financial constraints, it means in real-life terms that a postdoc with up to three years of experience is currently making les

Written byFrieda Reichsman
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Concerning the news article "Postdocs get a pay raise, but other issues remain,"1 it is important to note that the pay raise being received by NIH-funded postdocs applies only to those paid from NIH grants awarded after October 1998. Any postdoc who is being paid from an NIH grant dated prior to October 1998 does not receive the increase. While this may be attributed to financial constraints, it means in real-life terms that a postdoc with up to three years of experience is currently making less money than a new postdoc with no experience. Not that any postdoc would begrudge the raising of salaries; it's so obviously long overdue. Of course, this is a temporary circumstance, and the disparity will disappear in a few years' time. Some principal investigators may even find creative ways to enhance the lot of their current postdocs. But for those postdocs that experience the disparity, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies